Anastomosis Devices Market

The Anastomosis Devices Market is valued at USD 5.1 Bn in 2026 and is projected to reach USD 8.4 Bn, growing at a CAGR of 6% by 2033.

Anastomosis Devices Market Benefits from Growing Demand for Minimally Invasive Surgical Procedures

One of the key elements driving the anastomosis devices market expansion is the rise in cardiovascular illnesses in general. Another factor influencing the market expansion is the unhealthful way of life that a significant portion of the global population leads. Other significant factors contributing to the development of prosperous market growth opportunities include the rising demand for minimally invasive procedures and the expanding use of anastomosis devices in various other surgical procedures, including orthopedic and ophthalmic procedures. Greater emphasis on better patient outcome will propel the adoption of cutting-edge technologies in anastomosis devices and support the expansion of market. For instance, EEA Circular Stapler with Tri-Staple Technology was introduced in December 2020 by India Medtronic Private Limited, a fully-owned subsidiary of Medtronic. It is the first 3-row circular stapler that is recommended for use during colorectal surgeries.

The anastomosis devices market is expanding due to the development of technologically improved products and advantageous reimbursement scenarios in cardiac surgeries such as Coronary Bypass Graft Surgery (CABG), open-heart valve replacement, and angioplasty in developed nations. For instance, Medicare Part B covers complete Cardiac Rehabilitation (C.R.) programs, coronary artery bypass graft surgery, coronary angioplasty, valve repair & replacement, and other medical procedures. However, the market growth rate will be slowed by anastomotic problems such as leakage and a lack of awareness in developing and undeveloped economies.

Anastomosis Devices Market: COVID-19 Impact

The COVID-19 epidemic harmed market predictions because there was a severe lack of medical equipment required to carry out complicated surgery. The demand-supply imbalance for essential tools like anastomosis devices was widening, which slowed the development of the healthcare industry. However, the demand for anastomosis devices is anticipated to expand significantly as the situation gradually improves because the virus was also to blame for an increase in cardiovascular cases globally. Manufacturers can take advantage of the rising demand for medical supplies to maintain a sufficient and ongoing supply of personal protective equipment in the market. Due to these reasons, COVID-19 is anticipated to have a big effect on the anastomosis devices market.

Global Increase in Number of Surgical Operations Supports Anastomosis Devices Market Expansion

A stunning 310 million major procedures are performed worldwide each year, with 20 million occurring in Europe and 40–50 million occurring in the U.S. Two variables contributing to the increased number of surgeries are the growing senior population around the world and the prevalence of chronic diseases. In addition to a growth in older adults, lifestyle disorders like cancer, diabetes, hypertension, obesity, and heart conditions are becoming more common worldwide. As more anastomosis operations are conducted internationally, there will likely be greater demand for equipment. Less scarring, faster healing, and less blood loss are all made possible by these instruments.

Expanding Healthcare Markets in Developing Nations to Foster Anastomosis Devices Market

Significant growth opportunities exist for major market players in emerging markets, like South Korea, Malaysia, Vietnam, South Korea, Africa, Israel, Saudi Arabia, and the United Arab Emirates. It is due to their lax regulatory requirements, improved healthcare facilities, expanding patient populations, and rising healthcare costs. Additionally, compared to industrialized nations, the regulatory regulations in the Asia-Pacific area are more flexible and business-friendly. It has led important players in the anastomosis devices market to concentrate on growing nations along with the escalating competition in developed areas.

Expensive Devices, and Stringent Clinical Data Requirements Associated with New Goods Will Limit Anastomosis Devices Market Expansion

Anastomosis devices, such as surgical adhesives and sealants, are made through an expensive procedure. Large R&D expenditures are necessary to develop new goods that successfully meet anastomosis devices market demands. Product development is characterized by the costly production process (freeze-drying), chilled storage, and difficult device assembly. Additionally, surgical staplers are more expensive than sutures. The outrageous price of this equipment drives up the cost of surgical procedures even further. The rising cost of surgical staplers is expected to constrain demand, especially in developing countries occasionally. Healthcare providers emphasize the need to contain healthcare costs and lessen the financial burden on patients.

Disposable Category Dominates Anastomosis Devices Market due to Presence of a Wider Range of Disposable Anastomotic Items

The disposable category held the largest anastomosis devices market share. It is anticipated that it will continue to rule the market during the forecast period due to a wider range of disposable anastomotic items being offered and increased market penetration. The bulk of large players is engaged in the manufacture of throwaway goods. These products reduce the likelihood of cross-contamination, surgical site infections (SSI), and other illnesses associated with healthcare (HAI). Additionally, disposable anastomotic devices have the advantage of not requiring reprocessing between uses, reducing reprocessing costs and speeding up the process in general. The advantages above will cause this sector to grow at a steady rate. Besides, the market is seeing the emergence of a new sector called the reusable anastomotic device. Over the predicted term, a profitable rate is anticipated. In the upcoming years, the segment's expansion is expected to be fueled by many important aspects, including the creation of technologically improved products and the growing desire to reduce biomedical waste.

Cardiovascular Surgery Dominant Category in Anastomosis Devices Market with Rising Usage of Numerous Tools in Various Cardiac Procedures

The cardiovascular surgery category dominated the anastomosis devices market in 2021. The market is predicted to have the biggest market share, by application, for cardiovascular surgery. This dominance results from the rising usage of numerous tools in various cardiac procedures, including surgical staplers, surgical sealants, and surgical adhesives. The effectiveness of these devices in lowering the risk of complications and decreasing anastomotic leaks can be related to the rise in demand for them in aortic surgery, arrhythmia surgery, myectomy, and CABG procedures. Additionally, the segment is growing due to the need for technologically sophisticated items caused by the rise in heart illnesses.

On the other hand, it is projected that the gastrointestinal surgeries segment will see the largest rate during the forecast period. The rise in gastrointestinal cancer cases globally may be to attributed for the expansion of anastomosis devices market. As stated by American Cancer Society projections for 2021, stomach cancer will impact roughly 28,612 people and result in 11,671 fatalities in the country. Thus, it is anticipated that the segment will develop faster as surgery becomes a standard care component for various stages of stomach cancer.

North America Leads Anastomosis Devices Market as Cardiovascular Diseases Become More Prevalent

Over the forecast period, it is expected that the North American market will account for the largest revenue share. Multiple cardiovascular indications, such as CAD, strokes, and stomach malignancies, such as adenocarcinoma, lymphoma, etc., are becoming more prevalent globally, which has led to an increase in surgical procedures and a consequent rise in the need for these surgical devices. Additionally, according to statistics released in January 2020 by the American Cardiac Association, approximately half of the population in the United States has a heart condition of some kind, such as high blood pressure, heart disease, etc. Equipment for monitoring and diagnosing cardiovascular systems became necessary as heart disease became more widespread. As a result, the anastomosis devices market in the area is driven by the greater need for these devices during surgical procedures. The region's excellent revenue share propels the global market due to its sedentary lifestyle and growing geriatric population with chronic disorders.

Asia Pacific market is anticipated to experience stable revenue growth throughout the forecast period. The major Asian contributors are Japan, China, and India. Due to the region's improving economic conditions, rising healthcare awareness, and growing elderly population, the regional market is anticipated to grow faster throughout the forecast period. Aged adults are more prone to digestive and cardiovascular illnesses, making them a sizable market for the industry. The market is expected to be driven by growing anastomosis device demand and rising company interest in expanding its regional presence. Additionally, the regional anastomosis devices market benefits from rising R&D activity and healthcare spending.

Global Anastomosis Devices Market: Competitive Landscape

In March 2021, FDA granted VIOLA's marketing authorization, which Vascular Graft Solutions Ltd. has now received. It is a new device for proximal anastomosis without a clamp in a coronary artery bypass graft. Similarly, in November 2020, the United States Food & Drug Administration designated the self-forming magnetic compression anastomosis device as a breakthrough device, according to G.I. Windows Medical Corp.

A few the global anastomosis devices market players are 

• Johnson & Johnson / Ethicon
• Medtronic plc
• Dextera Surgical Inc.
• Synovis Micro Companies Alliance, Inc.
• Vitalitec International Inc.
• MAQUET Holding B.V. & Co. KG (Getinge Group)
• LivaNova PLC
• Peters Surgical
• Artivion, Inc.
• Braun Melsungen AG
• CONMED Corporation
• Teleflex Incorporated
• Smith & Nephew plc
• Intuitive Surgical, Inc.
• Becton, Dickinson and Company (BD)

Global Anastomosis Devices Market is Segmented as Below:

By Product

• Surgical Staplers
• Surgical Sutures
• Surgical Sealants and Adhesives

By Application

• Cardiovascular & Thoracic Surgery
• Gastrointestinal Surgery
• Orthopedic Surgery
• Gynecological Surgery
• Other Applications

By End User

• Hospitals
• Ambulatory Surgery Centers
• Other End Users

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa